Literature DB >> 26365372

Thromboembolic events in patients with severe pandemic influenza A/H1N1.

Lone Sølling Avnon1, Daniela Munteanu2, Alexander Smoliakov3, Alan Jotkowitz4, Leonid Barski5.   

Abstract

BACKGROUND: The 2009 pandemic influenza A/H1N1 developed as a novel swine influenza which caused more diseases among younger age groups than in the elderly. Severe hypoxemic respiratory failure from A/H1N1 pneumonia resulted in an increased need for ICU beds. Several risk groups were identified that were at a higher risk for adverse outcomes. Pregnant women were a particularly vulnerable group of patients The CDC reported on the first ten patients with severe illness and acute hypoxemic respiratory failure associated with A/H1N1 infection, none of whom were pregnant, but they noticed that half of the patients had a pulmonary embolism.
METHODS: During a four-month period from September to December 2009, 252 patients were admitted to our hospital with confirmed pandemic influenza H1N1 by real-time reverse transcriptase-polymerase chain reaction test (rRT-PCR). We cared for twenty patients (7.9%) admitted to MICU with severe A/H1N1. Results on Thrombotic events were identified in five (25%) of our critically ill patients.
CONCLUSIONS: We recommend that patients with severe influenza A/H1N1 pneumonitis and respiratory failure be administered DVT prophylaxis in particular if there are additional risk factors for TVE. Further prospective studies on the relationship of influenza A/H1N1 and VTE are needed.
Copyright © 2015 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Influenza A/H1N1; Mortality; Pregnancy; Thromboembolism

Mesh:

Year:  2015        PMID: 26365372     DOI: 10.1016/j.ejim.2015.08.017

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  19 in total

1.  Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?

Authors:  Eleni E Ladikou; Helena Sivaloganathan; Kate M Milne; William E Arter; Roshan Ramasamy; Ramy Saad; Simon M Stoneham; Barbara Philips; Alice C Eziefula; Timothy Chevassut
Journal:  Clin Med (Lond)       Date:  2020-07-21       Impact factor: 2.659

2.  H1N1-Induced Venous Thromboembolic Events? Results of a Single-Institution Case Series.

Authors:  Evangelos Dimakakos; Dimitra Grapsa; Ioannis Vathiotis; Aggeliki Papaspiliou; Meropi Panagiotarakou; Emmanouil Manolis; Konstantinos Syrigos
Journal:  Open Forum Infect Dis       Date:  2016-12-20       Impact factor: 3.835

3.  Infrarenal Aorta Thrombosis Associated with H1N1 Influenza A Virus Infection.

Authors:  Can Hüzmeli; Mustafa Saglam; Ali Arıkan; Barıs Doner; Gulay Akıncı; Ferhan Candan
Journal:  Case Rep Infect Dis       Date:  2016-10-31

4.  Deep cerebral venous thrombosis mimicking influenza-associated acute necrotizing encephalopathy: a case report.

Authors:  Daisuke Taniguchi; Sho Nakajima; Arisa Hayashida; Takuma Kuroki; Hiroto Eguchi; Yutaka Machida; Nobutaka Hattori; Hideto Miwa
Journal:  J Med Case Rep       Date:  2017-09-26

Review 5.  Methodological Issues and Controversies in COVID-19 Coagulopathy: A Tale of Two Storms.

Authors:  Samuel A Berkman; Victor F Tapson
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

6.  COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection.

Authors:  Kyla Casey; Alexander Iteen; Reese Nicolini; Jonathan Auten
Journal:  Am J Emerg Med       Date:  2020-04-08       Impact factor: 2.469

Review 7.  Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19.

Authors:  Rhian M Touyz; Marcus O E Boyd; Tomasz Guzik; Sandosh Padmanabhan; Linsay McCallum; Christian Delles; Patrick B Mark; John R Petrie; Francisco Rios; Augusto C Montezano; Robert Sykes; Colin Berry
Journal:  CJC Open       Date:  2021-06-16

8. 

Authors:  Marcos Arêas Marques; Fernanda Penza Adami de Sá; Otília Lupi; Patricia Brasil; Arno von Ristow
Journal:  J Vasc Bras       Date:  2017 Jan-Mar

9.  COVID-19 coagulopathy, thrombosis, and bleeding.

Authors:  Noel C Chan; Jeffrey I Weitz
Journal:  Blood       Date:  2020-07-23       Impact factor: 25.476

10.  Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis.

Authors:  Angelo Santoliquido; Angelo Porfidia; Antonio Nesci; Giuseppe De Matteis; Giuseppe Marrone; Enrica Porceddu; Giulia Cammà; Igor Giarretta; Massimo Fantoni; Francesco Landi; Antonio Gasbarrini; Roberto Pola; Maria E D'Alfonso; Maria R Lo Monaco
Journal:  J Thromb Haemost       Date:  2020-08-27       Impact factor: 16.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.